Search Within

Jose T Baselga

Formats
  1. Meeting Abstract (241)
  2. Journal Article (233)
  3. Conference Paper (4)
  4. Research Letter (3)
  5. Book Section (2)
  6. Review (1)
Groups
  1. Department of Medicine (197)
  2. Solid Tumor Oncology Division (192)
  3. Breast Medicine Service (149)
  4. GSK Faculty (128)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (108)
  6. Human Oncology and Pathogenesis Program (97)

More Groups

People
  1. David Hyman (68)
  2. Maurizio Scaltriti (63)
  3. Clifford Hudis (57)
  4. Michael Berger (56)
  5. Larry Norton (51)
  6. Sarat Chandarlapaty (48)

More People

Years
  1. 2021 (5)
  2. 2020 (11)
  3. 2019 (25)
  4. 2018 (58)
  5. 2017 (68)
  6. 2016 (67)

More Years

Publications
  1. Cancer Research (109)
  2. Journal of Clinical Oncology (92)
  3. Annals of Oncology (29)
  4. Clinical Cancer Research (29)
  5. European Journal of Cancer (25)
  6. Cancer Discovery (13)

More Publications

Publishers
  1. American Association for Cancer Research (163)
  2. American Society of Clinical Oncology (97)
  3. Oxford University Press (41)
  4. Elsevier Inc. (39)
  5. Nature Publishing Group (30)
  6. Springer (16)

More Publishers

Results (484)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: Subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
    Journal Article

    Miles, D.; Baselga, J.; Amadori, D.; Sunpaweravong, P.; Semiglazov, V.; Knott, A.; Clark, E.; Ross, G.; Swain, S. M.
    Breast Cancer Research and Treatment (2013)

    Fulltext@MSK | Save
  • Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors
    Journal Article

    Eskens, F. A. L. M.; Ramos, F. J.; Burger, H.; O'Brien, J. P.; Piera, A.; de Jonge, M. J. A.; Mizui, Y.; Wiemer, E. A. C.; Carreras, M. J.; Baselga, J.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Neoadjuvant therapy as a platform for drug development and approval in breast cancer
    Journal Article

    Bardia, A.; Baselga, J.
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Clinical response to a lapatinib-based therapy for a Li-Fraumeni Syndrome patient with a novel HER2V659E mutation
    Journal Article

    Serra, V.; Vivancos, A.; Puente, X. S.; Felip, E.; Silberschmidt, D.; Caratù, G.; Parra, J. L.; De Mattos-Arruda, L.; Grueso, J.; Hernández-Losa, J.; more...
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • AACR cancer progress report 2013
    Journal Article

    Sawyers, C. L.; Abate-Shen, C.; Anderson, K. C.; Barker, A.; Baselga, J.; Berger, N. A.; Foti, M.; Jemal, A.; Lawrence, T. S.; Li, C. I.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial
    Journal Article

    Azim, H. A.; Rothe, F.; Aura, C. M.; Bavington, M.; Maetens, M.; Rouas, G.; Gebhart, G.; Gamez, C.; Eidtmann, H.; Baselga, J.; more...
    Breast (2013)

    Fulltext@MSK | Save
  • Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial
    Journal Article

    Metzger-Filho, O.; Procter, M.; de Azambuja, E.; Leyland-Jones, B.; Gelber, R. D.; Dowsett, M.; Loi, S.; Saini, K. S.; Cameron, D.; Untch, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel
    Journal Article

    Cortes, J.; Swain, S. M.; Kudaba, I.; Hauschild, M.; Patel, T.; Grincuka, E.; Masuda, N.; McNally, V.; Ross, G.; Brewster, M.; more...
    Anti-Cancer Drugs (2013)

    Fulltext@MSK | Save
  • Health-Related quality-Of-Life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer
    Journal Article

    Cortes, J.; Baselga, J.; Im, Y. H.; Im, S. A.; Pivot, X.; Ross, G.; Clark, E.; Knott, A.; Swain, S. M.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2- advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy
    Journal Article

    Campone, M.; Beck, J. T.; Gnant, M.; Neven, P.; Pritchard, K. I.; Bachelot, T.; Provencher, L.; Rugo, H. S.; Piccart, M.; Hortobagyi, G. N.; more...
    Current Medical Research and Opinion (2013)

    Fulltext@MSK | Save